Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyethylene Glycol Loxenatide Plus LNG-IUS in Women With Endometrial Atypical Hyperplasia
NCT05172999Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of polyethylene glycol loxenatide in endometrial atypical hyperplasia (AEH), sponsored by Fudan University. Started Jan 2022; status: completed.
02
Drugs
polyethylene glycol loxenatide
03
Conditions
endometrial atypical hyperplasia (AEH)
Beyond the preview
Go deeper on NCT05172999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172999.